Search

everythinglearnresearchcommunity

for

Search:↓

CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.

Higher MPV and CRP levels may indicate more severe alopecia areata.

Ectoin helps prevent cortisone-induced skin problems and supports skin health.

Ritlecitinib improves hair regrowth in alopecia areata over 24 months.

ECCL should be considered in patients with specific skin and eye lesions.

EK significantly improved wound healing and reduced infection in burn wounds.

Rabbits lacking the Hoxc13 gene show similar hair and skin issues to humans with ECTD-9, making them good for research on this condition.

Emotional Freedom Techniques (EFT) treatment improved seed germination and growth, suggesting mood affects seed viability.

14,15-EET may help reduce poststroke pain by affecting certain brain proteins.

EPDS can cause recurring scalp sores and hair loss if not treated.

The protocol is easy to use, but reliable results need the same person to assess each time.

CRISPR/Cas9 and prime editing can potentially fix skin disorder genes safely and effectively.

CLASI is a valid tool for assessing skin activity and damage in lupus patients.

The new scalp coverage scoring method accurately measures hair loss and growth in men.

The AAcQLI is a promising tool for assessing quality of life in children with alopecia areata.

A genetic mutation in the EDA gene causes hypohidrotic ectodermal dysplasia in cats.

Adults with certain skin conditions may have higher levels of inflammation in their body.

Eclipta alba flavonoids may help treat diabetes by effectively inhibiting Aldose reductase.

The 595-nm pulsed dye laser effectively reduces symptoms of EFFC with minimal side effects.

Eclipta alba may improve memory and help treat Alzheimer's disease.

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

Alcoholic extract of Eclipta alba may help treat allergies and is safe at high doses.

A cat's poor wound healing was linked to a genetic deletion in the COL5A1 gene.

A new EDA gene variant causes X-linked hypohidrotic ectodermal dysplasia in a Chinese family.

Risankizumab effectively treats and maintains skin clearance in moderate-to-severe psoriasis.

A patient with Ehlers-Danlos Syndrome improved after treatment for fat malabsorption and essential fatty acid deficiency.

The method is quick and effective for testing steroid 5 alpha-reductase inhibitors.

Erdr1 could be a new marker for diagnosing hair loss.

Early diagnosis and treatment are crucial for CAPS, and Eculizumab can be effective.